What is machineMD?
machineMD is a Swiss-based medical device company focused on advancing the measurement of brain function through innovative neuro-ophthalmology techniques. The company has developed 'nes,' a non-invasive device designed for the automated assessment of critical visual parameters including eye movements, pupil responses, and visual fields. This technology aims to significantly enhance diagnostic quality within healthcare systems, targeting both secondary and primary care settings. By providing accessible diagnostic tools, machineMD seeks to bridge the gap for patients who currently lack direct access to specialized ophthalmological care. The company's foundation at the University Hospital of Bern highlights its commitment to rigorous scientific development and clinical application.
How much funding has machineMD raised?
machineMD has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2022): $3.2M with participation from Guido Fluri Foundation
Key Investors in machineMD
Guido Fluri Foundation
The Guido Fluri Foundation is an entity that has participated in the company's funding rounds. Its specific investment focus within the medical technology sector is not detailed.
What's next for machineMD?
The recent major strategic investment positions machineMD for significant scaling and further development of its diagnostic technology. With a focus on improving the efficiency and quality of medical examinations, the company is poised to expand its reach within healthcare networks. Future growth will likely involve broader clinical adoption of the 'nes' device, potentially leading to new partnerships and market penetration in regions seeking to enhance diagnostic capabilities for neurological and ophthalmological conditions. The enterprise-level funding context suggests a trajectory towards substantial market impact and potential future funding rounds to support global expansion.
See full machineMD company page
